Danaher Corp has won U.S. antitrust approval to buy General Electric’s biopharmaceutical business, GE Biopharma, for $21.4 billion on condition it sell some assets, the Federal Trade Commission said on Thursday.
Read the full article: Danaher Wins US Approval to Buy GE Biopharma, with Conditions //
Source: https://www.reuters.com/article/gebiopharma-ma-danaher/danaher-wins-us-approval-to-buy-ge-biopharma-with-conditions-idUSL1N2BC2KW